Strategy & Innovation Diagnostics for Competitive Clarity
Helping established HealthTech, MedTech and Wellbeing businesses diagnose issues and opportunities across business strategy, innovation strategy, product strategy and product innovation to strengthen competitiveness and increase the probability of product success.
Why established businesses lose their competitive edge
Listen to Why EDGE Diagnostics Exists (2 min) • Narration: Why established businesses can gradually lose competitiveness and where hidden risks and renewal opportunities may lie
As organisations mature, complexity often builds gradually across products, operations, systems and decision-making. What once worked effectively can become harder to sustain as markets evolve, customer expectations change and legacy structures begin slowing progress.
In HealthTech, MedTech and Wellbeing environments, this rarely happens through one major failure. More often, organisations gradually lose adaptability, responsiveness and competitive focus as products, operations and strategic priorities become harder to align over time.
Innovation begins slowing. Decision-making becomes more cautious or fragmented. Operational complexity increases while products, systems and ways of working become more difficult to evolve confidently.
Many leadership teams seek help because performance is no longer matching expectations. Innovation slows, competitiveness weakens and transformation initiatives fail to deliver expected results. The visible symptoms are rarely the underlying cause. Each EDGE Diagnosis helps identify the causes of strategic drift across business strategy, innovation, products, markets and organisational capability, and the opportunities to renew long-term competitiveness before deciding what to do next.
How We Help
Identifying the causes of strategic drift and the opportunities to strengthen long-term competitiveness
Listen to How EDGE Diagnostics Helps (2 min) • Narration: How we uncover root causes, challenge legacy assumptions and identify what really needs attention
Each EDGE Diagnosis service helps leadership teams identify where complexity, outdated assumptions or organisational friction are weakening competitiveness, adaptability and long-term performance before deciding what strategic action should be taken.
The diagnostics are designed to help organisations identify where:
→ products are losing relevance or differentiation
→ customer value and market position are weakening
→ operational complexity is slowing execution
→ organisational structures and ways of working are becoming harder to adapt effectively
The work focuses on helping leadership teams understand where products, systems and organisational capabilities may need renewing, strengthening or realigning to support future growth, competitiveness and long-term relevance before larger transformation, repositioning or strategic change initiatives become more urgent, disruptive or costly to implement.
Rather than overwhelming organisations with frameworks or unnecessary complexity, the emphasis remains practical, commercially grounded and focused on helping businesses strengthen adaptability, competitiveness and strategic direction with greater clarity and confidence.
Our EDGE Dignostic Services
Listen to EDGE Diagnostic Services (3 min) • Narration: What our Product, Market and Organisation diagnostics can help you investigate
Diagnostics for Strengthening Product Competitiveness
Understanding where products, innovation capabilities and competitive differentiation may require renewal as markets, technologies and customer expectations evolve.
Explore services:
Diagnostics for Strengthening Market Competitiveness
Understanding where customer value, market relevance and strategic positioning may be weakening within changing competitive environments.
Explore services:
Diagnostics for Strengthening Organisation & Leadership
Understanding where operational performance, organisational alignment and execution capability may be limiting future adaptability and transformation success.
Explore services:
Together, these diagnostics help leadership teams understand where strategic drift, organisational complexity or legacy thinking may be weakening competitiveness, slowing innovation or limiting future adaptability.
EDGE Diagnostics forms part of JASSELL Advisory’s wider Strategy & Innovation Consulting practice for HealthTech, MedTech and Wellbeing businesses, connecting product, market and organisational factors to strengthen competitiveness, renewal and long-term strategic performance.
Product Strategy Diagnosis
See your product clearly again.
Issues
Product strategy rarely fails suddenly, it drifts gradually over time. What once felt differentiated, commercially strong and closely aligned to market needs can slowly become less relevant as customer expectations shift, competitors reposition and internal assumptions no longer reflect market reality.
In HealthTech, MedTech and other regulated product environments, this drift is often amplified by changing regulation, technological acceleration and increasing pressure to deliver clearer customer and commercial value in increasingly competitive markets.
Aim
This diagnostic helps leadership teams assess whether product strategy remains relevant, differentiated and aligned with current market reality — before strategic misalignment begins weakening competitiveness, growth or long-term product value.
Why it matters
Mature organisations rarely lose momentum because their products stop functioning. More often, they lose momentum because the strategy behind the product no longer reflects where value is being created or how markets are evolving.
Over time, differentiation softens, competitive positioning weakens and products become increasingly difficult to evolve with confidence. Internal assumptions that once supported growth may no longer reflect customer expectations, competitive behaviour or the wider strategic landscape.
Without periodic strategic renewal, organisations risk investing heavily in products and roadmaps that are becoming progressively less relevant to the markets they serve.
The risks
Research from MIT Sloan Management Review (2020) and the International Journal of Managerial Studies and Research (2020) shows that strategic drift often emerges when organisations fail to reassess market assumptions, customer expectations and competitive positioning as external conditions evolve.
These risks rarely emerge through one major strategic mistake. More often, they build gradually through weakening differentiation, outdated strategic narratives and product decisions that become increasingly disconnected from changing market realities and customer priorities.
How we help
The diagnostic examines product positioning, market alignment, customer expectations, competitive dynamics and strategic assumptions to identify where relevance, differentiation or strategic clarity may be weakening.
The work helps leadership teams understand what has changed across the market landscape, where strategic drift may be occurring and what requires attention before larger repositioning, investment or renewal decisions move forward.
What you recieve
→ review of product strategy, positioning and market alignment
→ assessment of customer expectations, value drivers and competitive dynamics
→ identification of relevance gaps, weakening differentiation and strategic drift
→ evaluation of strategic assumptions and long-term product direction
→ product strategy renewal and repositioning recommendations
What improves
Organisations leave with clearer visibility of product strategy risks, stronger understanding of market and competitive alignment and better-informed decisions around repositioning, renewal and future strategic direction.
The result is a more focused and strategically aligned product direction – with stronger differentiation, improved relevance and greater confidence in future growth and investment decisions.
Innovation System Diagnosis
Unblock the system that turns ideas into value.
Issues
Innovation systems rarely fail all at once – they weaken gradually over time. What was once fast-moving, collaborative and commercially focused can slowly become fragmented, risk-averse or constrained by legacy structures, unclear ownership and slower decision-making.
In HealthTech, MedTech and other regulated product environments, these challenges are often amplified by increasing operational complexity, governance requirements and the pressure to innovate safely while maintaining performance and compliance.
Aim
This diagnostic helps leadership teams assess whether the innovation system remains capable of consistently converting ideas into valuable products, improvements and strategic opportunities — before system drift begins weakening innovation capability, adaptability or long-term competitiveness.
Why it matters
Mature organisations rarely struggle because they lack ideas. More often, they struggle because the systems responsible for discovering, evaluating, prioritising and delivering innovation no longer work effectively together.
Over time, decision-making slows, collaboration weakens and promising ideas fail to progress beyond discussion or isolated experimentation. Teams become siloed, governance becomes heavier and innovation activity drifts away from real customer, operational or commercial needs.
Without a healthy innovation system, organisations risk becoming slower to adapt, less competitive and increasingly unable to convert innovation effort into meaningful value.
The risks
Research from Harvard Business Review (2019), Oxford Review of Economic Policy (2018) and Gartner Research (2022) shows that innovation performance weakens significantly when governance structures, decision pathways and organisational capabilities fail to evolve alongside changing technologies, markets and customer expectations.
These risks rarely emerge through one major failure. More often, they build gradually through fragmented ownership, slow decision-making, weak discovery practices and systems that make it increasingly difficult to move ideas from exploration into scalable, commercially viable outcomes.
How we help
The diagnostic examines governance structures, decision pathways, collaboration patterns, innovation workflows, discovery practices and capability alignment to identify where friction, fragmentation or system constraints may be limiting innovation performance.
The work helps leadership teams understand how ideas currently move through the organisation, where bottlenecks or capability gaps exist and what requires attention before larger transformation, investment or innovation renewal decisions move forward.
What you recieve
→ review of innovation governance, workflows and decision structures
→ assessment of collaboration patterns, discovery practices and capability alignment
→ identification of bottlenecks, system constraints and innovation gaps
→ evaluation of innovation flow, prioritisation and delivery effectiveness
→ innovation system improvement and renewal recommendations
What improves
Organisations leave with clearer visibility of innovation system risks, stronger understanding of how innovation performance is being constrained and better-informed decisions around capability development, governance and future innovation investment.
The result is a more connected and commercially effective innovation system — with improved flow, stronger decision-making and greater confidence in the organisation’s ability to turn ideas into meaningful value.
Customer Experience Diagnosis
See your experience the way customers actually feel it.
Issues
As organisations mature, customer experience often becomes shaped more by internal structures and legacy processes than by how customers actually experience value. What once felt intuitive, responsive and aligned can gradually become more difficult for customers to navigate, understand or gain value from as products, channels and service interactions evolve over time.
In HealthTech, MedTech and other regulated product environments, this directly affects adoption, trust, safe use and long-term customer confidence. Small points of friction, inconsistency or misalignment can gradually weaken how customers perceive value — even when product quality remains strong.
Aims
This diagnostic helps leadership teams assess whether customer experience and value perception remain aligned with evolving customer expectations and real-world behaviour before declining engagement, trust or relevance begin affecting long-term performance.
Why it matters
Customer experience is one of the strongest drivers of loyalty, retention and long-term commercial value. As organisations evolve, complexity often accumulates across systems, teams and touchpoints, making experiences harder to deliver consistently and clearly.
Over time, value propositions weaken, customer journeys become fragmented and organisations risk losing alignment with how customers actually evaluate trust, usability and perceived value. In regulated sectors, these gaps can have an even greater impact because confidence, clarity and consistency directly influence adoption and long-term engagement.
Without regular reassessment, organisations risk optimising internal systems while gradually degrading the customer experience itself.
The risks
Research from Harvard Business Review (2013), the Journal of Service Research (2007) and Forrester Research (2021) shows that fragmented customer experiences, weak insight practices and inconsistent value delivery are strong predictors of declining loyalty, increased churn and reduced long-term customer value.
These risks rarely emerge through one major failure. More often, they build gradually through disconnected touchpoints, inconsistent communication, weak behavioural understanding and experiences that no longer reflect how customers perceive value in changing market environments.
How we help
The diagnostic examines customer journeys, service interactions, value perception, adoption behaviours and experience consistency to identify where friction, misalignment or declining relevance may be affecting customer confidence and engagement.
The work helps leadership teams understand how customers truly experience the organisation today, where experience gaps or value erosion may exist and what requires attention before larger transformation or repositioning decisions move forward.
What you recieve
→ review of customer journeys, touchpoints and experience consistency
→ assessment of value perception, trust and adoption behaviours
→ identification of friction, misalignment and customer experience gaps
→ evaluation of service, communication and engagement alignment
→ customer experience and value improvement recommendations
What improves
Organisations leave with clearer visibility of customer experience risks, stronger understanding of how value is perceived and better-informed decisions around experience improvement, customer alignment and long-term differentiation.
The result is a more connected and customer-aligned experience – with stronger trust, improved engagement and greater confidence in how value is delivered across the organisation.
Strategic Position Diagnosis
See your strategic position with fresh eyes.
Issues
As markets evolve, mature organisations often find that the strategic foundations that once supported growth no longer fit current realities. What once differentiated the organisation can gradually lose relevance as customer expectations shift, competitors reposition and new technologies or business models reshape how value is created.
In HealthTech, MedTech and other regulated product environments, this drift can be amplified by changing regulation, increasing market complexity and evolving expectations around outcomes, trust and value delivery.
Aim
This diagnostic helps leadership teams assess whether strategic positioning, value creation and the way the organisation generates and captures value remain aligned with current and future market realities – before weakened relevance or strategic misalignment begin constraining competitiveness and growth.
Why it matters
Strong products alone do not guarantee long-term competitiveness. Organisations often lose momentum because the strategic logic beneath the business becomes outdated or increasingly disconnected from how customers, markets and competitors now behave.
Over time, value propositions soften, differentiation weakens and business models become harder to sustain as external conditions continue evolving. Internal assumptions that once supported growth may no longer reflect how value is perceived, delivered or monetised in the current market environment.
Without periodic strategic reassessment, organisations risk protecting legacy thinking while competitors redefine where and how value is created.
The risks
Research from the Strategic Management Journal (2007), Harvard Business School (2016) and OECD (2021) shows that strategic drift often emerges when organisations continue relying on outdated assumptions about customer value, competitive dynamics and market structure as external conditions evolve.
These risks rarely emerge through one major strategic failure. More often, they build gradually through weakening differentiation, outdated value propositions and business models that become increasingly disconnected from changing customer expectations, technological shifts and new market realities.
How we help
The diagnostic examines strategic positioning, customer value drivers, market dynamics, competitive narratives and business model alignment to identify where relevance, differentiation or commercial logic may be weakening.
The work helps leadership teams understand how strategic position has evolved, where assumptions or value mechanisms may no longer fit current realities and what requires attention before larger repositioning, transformation or renewal decisions move forward.
What you recieve
→ review of strategic positioning, market alignment and business model logic
→ assessment of customer value drivers, competitive dynamics and differentiation
→ identification of relevance gaps, value erosion and strategic misalignment
→ evaluation of value creation, delivery and commercial sustainability
→ strategic positioning and business model renewal recommendations
What improves
Organisations leave with clearer visibility of strategic and commercial risks, stronger understanding of market and competitive alignment and better-informed decisions around repositioning, business model evolution and long-term competitiveness.
The result is a more strategically aligned and commercially resilient organisation – with stronger clarity, improved differentiation and greater confidence in future growth and renewal decisions.
Operational Performance Diagnosis
See where operations are holding your organisation back.s.
Issues
In mature organisations, operational systems often become shaped by years of incremental change, legacy processes and growing organisational complexity. What once supported growth effectively can gradually become slower, more fragmented and increasingly difficult to align with evolving product, customer and regulatory demands.
In HealthTech, MedTech and other regulated product environments, this directly affects quality, compliance, responsiveness and the organisation’s ability to innovate reliably at pace. As complexity accumulates, inefficiencies, delays and performance gaps can begin developing beneath the surface long before major issues become visible.
Aim
This diagnostic helps leadership teams assess whether operational systems, manufacturing capability and supply-chain performance remain aligned with current business needs before inefficiency, fragility or operational strain begin constraining performance and adaptability.
Why it matters
Operational performance rarely weakens through one major failure. More often, inefficiencies accumulate gradually as processes become fragmented, systems struggle to adapt and operational complexity increases across products, suppliers and internal workflows.
Over time, rising costs, slower operational cycles, inconsistent quality and fragile supply chains can begin weakening resilience, reducing responsiveness and limiting the organisation’s ability to support innovation and future growth effectively.
Without operational clarity, organisations risk scaling complexity rather than strengthening capability.
The risks
Research from the Journal of Operations Management (2004), OECD (2020) and the U.S. Food and Drug Administration (2021) shows that operational drift often emerges when legacy processes, fragmented decision structures and weak quality integration fail to evolve alongside changing product, regulatory and supply-chain demands.
These risks rarely emerge through one major operational breakdown. More often, they build gradually through inefficiencies, weak resilience planning, capability gaps and systems that become increasingly difficult to coordinate, modernise or scale effectively over time.
How we help
The diagnostic examines workflows, operational systems, manufacturing capability, supply-chain resilience and quality management processes to identify where inefficiency, bottlenecks or operational misalignment may be limiting performance.
The work helps leadership teams understand how operations currently function, where operational strain or fragmentation may exist and what requires attention before larger optimisation, modernisation or transformation decisions move forward.
What you receive
→ review of workflows, operational systems and delivery performance
→ assessment of operational efficiency, manufacturing capability and supply-chain resilience
→ identification of bottlenecks, inefficiencies and operational risks
→ evaluation of quality integration, operational alignment and capability gaps
→ operational improvement and modernisation recommendations
What improves
Organisations leave with clearer visibility of operational risks, stronger understanding of system performance and better-informed decisions around efficiency, resilience and operational improvement priorities.
The result is a more reliable and scalable operational foundation — with improved consistency, reduced operational strain and greater confidence in the systems supporting long-term organisational performance.
Organisational Performance Diagnosis
See the organisation behind performance more clearly.
Issues
As organisations mature, performance increasingly depends on how effectively the organisation itself is structured, aligned and enabled to deliver. What once felt agile and closely connected can gradually become slower, more fragmented and harder to coordinate as complexity accumulates across teams, leadership structures and operational systems.
In HealthTech, MedTech and other regulated product environments, this directly affects execution, innovation, responsiveness and the organisation’s ability to adapt to changing market, regulatory and operational demands. As complexity increases, decision-making can slow, accountability becomes less clear and organisational energy can become increasingly dispersed across competing priorities.
Aim
This diagnostic helps leadership teams assess whether organisational structures, leadership capability and decision-making systems remain aligned with current business needs before organisational drift begins weakening performance, accountability or adaptability.
Why it matters
Organisational performance rarely weakens through one major failure. More often, misalignment builds gradually as responsibilities become unclear, decision-making slows and organisational structures evolve unevenly around changing business demands.
Over time, accountability weakens, collaboration becomes harder and capabilities drift away from what the organisation now requires to perform effectively. Teams may continue working hard while the organisation itself becomes increasingly difficult to coordinate, adapt or scale efficiently.
Without organisational clarity, businesses risk creating internal complexity that limits execution, slows innovation and reduces long-term resilience.
The risks
Research from MIT Sloan Management Review (2003), the Academy of Management Journal (2009) and OECD (2019) shows that organisational decline often accelerates when leadership alignment, decision-making structures and organisational capabilities fail to evolve alongside increasing complexity and changing strategic demands.
These risks rarely emerge through one visible organisational breakdown. More often, they build gradually through fragmented accountability, siloed behaviour, capability gaps and organisational systems that become increasingly disconnected from the realities of modern product, operational and market environments.
How we help
The diagnostic examines organisational structure, leadership alignment, decision-making pathways, capability development and cross-functional coordination to identify where organisational friction, weak alignment or capability constraints may be limiting performance.
The work helps leadership teams understand how the organisation currently functions, where organisational drift or capability gaps may exist and what requires attention before larger redesign, capability-building or transformation decisions move forward.
What you recieve
→ review of organisational structure, leadership alignment and decision-making systems
→ assessment of capability, accountability and cross-functional coordination
→ identification of organisational friction, capability gaps and performance constraints
→ evaluation of adaptability, execution effectiveness and organisational alignment
→ organisational improvement and capability development recommendations
What improves
Organisations leave with clearer visibility of organisational risks, stronger understanding of leadership and capability alignment and better-informed decisions around structure, accountability and organisational improvement priorities.
The result is a more aligned and adaptable organisation – with stronger execution, clearer accountability and greater confidence in the systems and capabilities supporting long-term performance and renewal.